MHRA and EMA Divergence in Clinical Trial Oversight
MHRA and EMA Divergence in Clinical Trial Oversight Divergence Between MHRA and EMA in Clinical Trial Oversight Following Brexit, the Medicines and Healthcare products Regulatory Agency (MHRA) assumed full authority over the regulation of clinical trials in the United Kingdom (UK), while the European Medicines Agency (EMA) retained oversight within the European Union (EU). While…
Read More “MHRA and EMA Divergence in Clinical Trial Oversight” »